tiprankstipranks
SAGE Therapeutics (SAGE)
NASDAQ:SAGE
US Market

SAGE Therapeutics (SAGE) Income Statement

Compare
925 Followers

SAGE Therapeutics Income Statement

Last quarter (Q4 2024), SAGE Therapeutics's total revenue was $12.82M, a decrease of -83.56% from the same quarter last year. In Q4, SAGE Therapeutics's net income was $-95.78M. See SAGE Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 41.24M$ 86.45M$ 7.69M$ 6.31M$ 1.11B
Gross Profit
$ 31.80M$ 84.30M$ 6.87M$ 5.75M$ 1.11B
Operating Expenses
$ 464.17M$ 630.76M$ 553.86M$ 466.66M$ 489.67M
Depreciation and Amortization
$ 1.03M$ 1.39M$ 1.12M$ 4.18M$ 2.63M
EBITDA
$ -409.49M$ -545.07M$ -545.87M$ -456.73M$ 626.60M
Operating Income
$ -432.37M$ -579.85M$ -546.99M$ -460.91M$ 596.23M
Other Income/Expenses
$ 31.70M$ 38.36M$ 14.21M$ 3.02M$ 9.85M
Pretax Income
$ -400.67M$ -541.49M$ -532.78M$ -457.89M$ 606.07M
Net Income
$ -400.67M$ -541.49M$ -503.27M$ -450.83M$ 606.07M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.59$ -9.05$ -8.49$ -7.68$ 11.66
Diluted EPS
$ -6.59$ -9.05$ -8.49$ -7.68$ 11.43
Weighted Average Shares Outstanding
60.77M 59.84M 59.31M 58.67M 51.98M
Weighted Average Shares Outstanding (Diluted)
60.77M 59.84M 59.31M 58.67M 53.00M
Currency in USD

SAGE Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis